When asked about loosening the restrictions on the HiSeq X Ten platform (i.e., running samples other than human whole genomes) during the recent Illumina investor call, Jay Flatley stated they were "at least a year away from opening it up in any way.”
Any guesses as to when one or both of the following will happen?
1) Allow customers to purchase a single HiSeq X system
2) Allow exomes and/or non-human samples to be run on the HiSeq X
Any guesses as to when one or both of the following will happen?
1) Allow customers to purchase a single HiSeq X system
2) Allow exomes and/or non-human samples to be run on the HiSeq X